Literature DB >> 29248479

Nanomaterials and molecular transporters to overcome the bacterial envelope barrier: Towards advanced delivery of antibiotics.

Rita S Santos1, Céu Figueiredo2, Nuno F Azevedo3, Kevin Braeckmans4, Stefaan C De Smedt5.   

Abstract

With the dramatic consequences of bacterial resistance to antibiotics, nanomaterials and molecular transporters have started to be investigated as alternative antibacterials or anti-infective carrier systems to improve the internalization of bactericidal drugs. However, the capability of nanomaterials/molecular transporters to overcome the bacterial cell envelope is poorly understood. It is critical to consider the sophisticated architecture of bacterial envelopes and reflect how nanomaterials/molecular transporters can interact with these envelopes, being the major aim of this review. The first part of this manuscript overviews the permeability of bacterial envelopes and how it limits the internalization of common antibiotic and novel oligonucleotide drugs. Subsequently we critically discuss the mechanisms that allow nanomaterials/molecular transporters to overcome the bacterial envelopes, focusing on the most promising ones to this end - siderophores, cyclodextrins, metal nanoparticles, antimicrobial/cell-penetrating peptides and fusogenic liposomes. This review may stimulate drug delivery and microbiology scientists in designing effective nanomaterials/molecular transporters against bacterial infections.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibiotics; Antimicrobial peptides; Bacteria; Cell-penetrating peptides; Liposomes; Metal nanoparticles; Nanomedicines; Oligonucleotides; Siderophores

Mesh:

Substances:

Year:  2017        PMID: 29248479     DOI: 10.1016/j.addr.2017.12.010

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  14 in total

1.  Comparing deep eutectic solvents and cyclodextrin complexes as curcumin vehicles for blue-light antimicrobial photodynamic therapy approaches.

Authors:  Eduardo Silva; Ivo M Aroso; Joana M Silva; Rui L Reis
Journal:  Photochem Photobiol Sci       Date:  2022-04-02       Impact factor: 4.328

Review 2.  Nanotargeting of Resistant Infections with a Special Emphasis on the Biofilm Landscape.

Authors:  Amjed Alabresm; Savannah L Chandler; Brian C Benicewicz; Alan W Decho
Journal:  Bioconjug Chem       Date:  2021-07-28       Impact factor: 4.774

Review 3.  Microfluidics for Peptidomics, Proteomics, and Cell Analysis.

Authors:  Rui Vitorino; Sofia Guedes; João Pinto da Costa; Václav Kašička
Journal:  Nanomaterials (Basel)       Date:  2021-04-26       Impact factor: 5.076

Review 4.  Self-Assembled Antimicrobial Nanomaterials.

Authors:  Ana Maria Carmona-Ribeiro
Journal:  Int J Environ Res Public Health       Date:  2018-07-04       Impact factor: 3.390

5.  Microfluidics as tool to prepare size-tunable PLGA nanoparticles with high curcumin encapsulation for efficient mucus penetration.

Authors:  Nashrawan Lababidi; Valentin Sigal; Aljoscha Koenneke; Konrad Schwarzkopf; Andreas Manz; Marc Schneider
Journal:  Beilstein J Nanotechnol       Date:  2019-11-19       Impact factor: 3.649

Review 6.  Mini Review on Antimicrobial Peptides, Sources, Mechanism and Recent Applications.

Authors:  Jaspreet Kaur Boparai; Pushpender Kumar Sharma
Journal:  Protein Pept Lett       Date:  2020       Impact factor: 1.890

7.  Insights into the molecular properties underlying antibacterial activity of prenylated (iso)flavonoids against MRSA.

Authors:  Sylvia Kalli; Carla Araya-Cloutier; Jos Hageman; Jean-Paul Vincken
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

Review 8.  Overcoming Multidrug Resistance in Bacteria Through Antibiotics Delivery in Surface-Engineered Nano-Cargos: Recent Developments for Future Nano-Antibiotics.

Authors:  Xinfu Yang; Wenxin Ye; Yajun Qi; Yin Ying; Zhongni Xia
Journal:  Front Bioeng Biotechnol       Date:  2021-07-08

Review 9.  From Genome to Drugs: New Approaches in Antimicrobial Discovery.

Authors:  Federico Serral; Florencia A Castello; Ezequiel J Sosa; Agustín M Pardo; Miranda Clara Palumbo; Carlos Modenutti; María Mercedes Palomino; Alberto Lazarowski; Jerónimo Auzmendi; Pablo Ivan P Ramos; Marisa F Nicolás; Adrián G Turjanski; Marcelo A Martí; Darío Fernández Do Porto
Journal:  Front Pharmacol       Date:  2021-06-09       Impact factor: 5.810

10.  An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets.

Authors:  Pablo Ivan Pereira Ramos; Darío Fernández Do Porto; Esteban Lanzarotti; Ezequiel J Sosa; Germán Burguener; Agustín M Pardo; Cecilia C Klein; Marie-France Sagot; Ana Tereza R de Vasconcelos; Ana Cristina Gales; Marcelo Marti; Adrián G Turjanski; Marisa F Nicolás
Journal:  Sci Rep       Date:  2018-07-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.